Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ANIDULAFUNGIN vs MICAFUNGIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ANIDULAFUNGIN vs MICAFUNGIN: Safety Overview

Metric ANIDULAFUNGIN MICAFUNGIN
Total FAERS Reports 701 3,117
Deaths Reported 325 1,068
Death Rate 46.4% 34.3%
Hospitalizations 287 1,121
Average Patient Age 53.3 yrs 49.7 yrs
% Female Patients 40.0% 38.7%
FDA Approval Date Feb 17, 2006 Apr 3, 2025
Manufacturer Roerig Zydus Pharmaceuticals USA Inc.
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription Discontinued